BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16386635)

  • 21. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
    Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
    Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.
    Vlieger AM; Boland GJ; Jiwa NM; de Weger RA; Willemze R; de Gast GC; Falkenburg JH
    Bone Marrow Transplant; 1992 Apr; 9(4):247-53. PubMed ID: 1318141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients.
    Lam KM; Oldenburg N; Khan MA; Gaylore V; Mikhail GW; Strouhal PD; Middeldorp JM; Banner N; Yacoub M
    J Heart Lung Transplant; 1998 Jun; 17(6):555-65. PubMed ID: 9662090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients.
    Limaye AP; Huang ML; Leisenring W; Stensland L; Corey L; Boeckh M
    J Infect Dis; 2001 Feb; 183(3):377-82. PubMed ID: 11133368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
    Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients.
    Storch GA; Buller RS; Bailey TC; Ettinger NA; Langlois T; Gaudreault-Keener M; Welby PL
    J Clin Microbiol; 1994 Apr; 32(4):997-1003. PubMed ID: 8027357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay.
    Hadaya K; Wunderli W; Deffernez C; Martin PY; Mentha G; Binet I; Perrin L; Kaiser L
    J Clin Microbiol; 2003 Aug; 41(8):3757-64. PubMed ID: 12904387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection.
    Kalpoe JS; Kroes AC; de Jong MD; Schinkel J; de Brouwer CS; Beersma MF; Claas EC
    J Clin Microbiol; 2004 Apr; 42(4):1498-504. PubMed ID: 15070995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the AmpliSensor PCR and the SHARP signal detection system for the early prediction of symptomatic CMV infection in solid transplant recipients.
    Rautenberg P; Lübbert C; Weers W; Boetel E; Schweichler J; Zhou L; Costard-Jäckle A; Kraemer-Hansen H; Harder TC
    J Clin Virol; 1999 Jun; 13(1-2):81-94. PubMed ID: 10405895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of human cytomegalovirus DNA by real-time PCR.
    Gault E; Michel Y; Dehée A; Belabani C; Nicolas JC; Garbarg-Chenon A
    J Clin Microbiol; 2001 Feb; 39(2):772-5. PubMed ID: 11158149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment.
    Siennicka J; Durlik M; Litwińska B; Chmura A; Lewandowska D; Lao M; Paczek L; Kańtoch M
    Acta Microbiol Pol; 1999; 48(1):61-71. PubMed ID: 10467696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
    Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
    Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
    Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ;
    J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.
    Sia IG; Wilson JA; Groettum CM; Espy MJ; Smith TF; Paya CV
    J Infect Dis; 2000 Feb; 181(2):717-20. PubMed ID: 10669361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of cytomegalovirus in liver transplant biopsies. A comparison of light microscopy, immunohistochemistry, duplex PCR and nested PCR.
    Brainard JA; Greenson JK; Vesy CJ; Tesi RJ; Papp AC; Snyder PJ; Western L; Prior TW
    Transplantation; 1994 Jun; 57(12):1753-7. PubMed ID: 8016881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients.
    Cortez KJ; Fischer SH; Fahle GA; Calhoun LB; Childs RW; Barrett AJ; Bennett JE
    J Infect Dis; 2003 Oct; 188(7):967-72. PubMed ID: 14513415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the AMPLICOR CMV, COBAS AMPLICOR CMV monitor and antigenemia assay for cytomegalovirus disease.
    Masaoka T; Hiraoka A; Ohta K; Tatsumi N; Watanabe S; Hotta T; Yabe H; Kato S; Aikawa A; Ohara T; Hasegawa A; Tanabe K; Toma H; Yasuoka A; Oka S
    Jpn J Infect Dis; 2001 Feb; 54(1):12-6. PubMed ID: 11326123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation.
    Tanaka Y; Kanda Y; Kami M; Mori S; Hamaki T; Kusumi E; Miyakoshi S; Nannya Y; Chiba S; Arai Y; Mitani K; Hirai H; Mutou Y;
    Bone Marrow Transplant; 2002 Sep; 30(5):315-9. PubMed ID: 12209354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, PP65 leukocytic antigenemia, and viremia.
    Eckart P; Brouard J; Legoff C; Freymuth F; Duhamel JF; Ryckelynck JP; Hurault De Ligny B
    Transplant Proc; 1996 Oct; 28(5):2806-7. PubMed ID: 8908069
    [No Abstract]   [Full Text] [Related]  

  • 40. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients.
    Pellegrin I; Garrigue I; Ekouevi D; Couzi L; Merville P; Merel P; Chene G; Schrive MH; Trimoulet P; Lafon ME; Fleury H
    J Infect Dis; 2000 Jul; 182(1):36-42. PubMed ID: 10882579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.